Vistagen stockholders elect all seven director nominees, approve say-on-pay, ratify auditors at 2024 annual meeting

Vistagen Therapeutics, Inc.

All seven director nominees elected, including CEO Shawn K. Singh with 14,540,841 votes for and 154,427 withheld.
Non-binding advisory vote on executive compensation approved: 13,758,902 for, 842,393 against, 93,973 abstain.
Ratification of KPMG LLP as independent auditor for FY2025 overwhelmingly approved: 21,277,275 for, 49,205 against.
Meeting held August 26, 2024; results reported in 8-K filed August 28, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.